Mononegaviruses are promising tools as oncolytic vectors and transgene delivery vectors for gene therapy and regenerative medicine. By using the Magnet proteins, which reversibly heterodimerize upon blue light illumination, photocontrollable mononegaviruses (measles and rabies viruses) were generated. The Magnet proteins were inserted into the flexible domain of viral polymerase, and viruses showed strong replication and oncolytic activities only when the viral polymerases were activated by blue light illumination. mononegavirus | measles virus | rabies virus | vector | oncolytic T he order Mononegavirales includes the Paramyxoviridae, Pneumoviridae, Bornaviridae, Filoviridae, and Rhabdoviridae families. Certain mononegaviruses are used for oncolytic viral therapy (1, 2). Oncolytic virotherapy is a new therapeutic option for cancer treatment using replication-competent viruses that preferentially target, replicate in, and kill cancer cells by inducing tumor-specific immune responses. They are also used as nonintegrating transgene delivery vectors to generate inducible pluripotent stem (iPS) cells (3). However, the designed removal of transgenes is still ideal to establish fully reprogrammed iPS cells. The control of viral replication also reduces the risk of adverse effects by oncolytic vectors. Here, we demonstrate a system for the spatiotemporal control of mononegavirus gene expression and replication.
Mononegaviruses are promising tools as oncolytic vectors and transgene delivery vectors for gene therapy and regenerative medicine. By using the Magnet proteins, which reversibly heterodimerize upon blue light illumination, photocontrollable mononegaviruses (measles and rabies viruses) were generated. The Magnet proteins were inserted into the flexible domain of viral polymerase, and viruses showed strong replication and oncolytic activities only when the viral polymerases were activated by blue light illumination. mononegavirus | measles virus | rabies virus | vector | oncolytic T he order Mononegavirales includes the Paramyxoviridae, Pneumoviridae, Bornaviridae, Filoviridae, and Rhabdoviridae families. Certain mononegaviruses are used for oncolytic viral therapy (1, 2) . Oncolytic virotherapy is a new therapeutic option for cancer treatment using replication-competent viruses that preferentially target, replicate in, and kill cancer cells by inducing tumor-specific immune responses. They are also used as nonintegrating transgene delivery vectors to generate inducible pluripotent stem (iPS) cells (3) . However, the designed removal of transgenes is still ideal to establish fully reprogrammed iPS cells. The control of viral replication also reduces the risk of adverse effects by oncolytic vectors. Here, we demonstrate a system for the spatiotemporal control of mononegavirus gene expression and replication.
The mononegavirus genome forms a ribonucleoprotein complex with the nucleocapsid protein and the RNA-dependent RNA polymerase composed of the large (L) protein and the cofactor proteins. The L protein exhibits the major catalytic activities for RNA synthesis, such as nucleotide polymerization, mRNA capping, and polyadenylation. Measles virus (MeV) belongs to the genus Morbillivirus, family Paramyxoviridae. The MeV polymerase L protein has a highly variable linker region, called the hinge 2 (H2) region, between the connector domain (CD) and the methyltransferase (MT) domain (4) (Fig. 1A) . We attempted to optically regulate the L protein polymerase activity by adding a photocontrollable domain at the H2 region, for which we used the Magnet system (5). The Magnet system consists of paired photoswitchable proteins-positive Magnet (pMag) and negative Magnet (nMag or nMagHigh1)-which heterodimerize upon blue light irradiation (5) (Fig. 1B) .
We attempted to generate recombinant MeVs (rMeVs) accommodating the photocontrollable L protein and enhanced green fluorescent protein (EGFP) using the method reported previously (6) . The MeV L protein was split into the N-terminal half region before position 1708/9 (Ln) and C-terminal half region after position 1708/9 (Lc). The position 1708/9 was located at the site corresponding to amino acid positions 1708 and 1709 in the H2 region. pMag was fused to the Ln C terminus (Ln-pMag), while nMagHigh1 was fused to the Lc N terminus (nMagHigh1-Lc) (Fig. 1B) . Ln-pMag and nMagHigh1-Lc were connected by a 26-amino acid flexible linker (Linker), generating Linker MagHigh L protein (L LMH ) (Fig. 1B) . Ln-pMag and nMagHigh1-Lc were also connected directly, generating Direct MagHigh L protein (L DMH ) ( (Fig. 1C) . They replicated efficiently under blue light illumination (Fig. 1D) . Notably, rMeV EGFP -L LMH showed low but detectable levels of replication capacity in the dark, while rMeV EGFP -L DMH showed none (Fig. 1D) . The replication of rMeV EGFP -L LMH was accelerated when infected cells, which were initially kept in the dark, were illuminated by blue light after a 7-d incubation period (Fig. 1F) . Conversely, the viral titers decreased when the illumination with blue light was stopped 3 d postinfection (p.i.) (Fig. 1F ). When monolayers of rMeV EGFP -L DMH -infected cells were illuminated by blue light through letter-shaped slits at the bottom of the culture dishes, EGFP-fluorescent letters emerged on the monolayers (Fig. 1G) .
We investigated whether the method used for MeV is applicable to rabies virus (RABV), a member of the genus Lyssavirus, family Rhabdoviridae. Since RABV and vesicular stomatitis virus, another member of Rhabdoviridae family, are used as tracers of neural circuits, this control method of virus gene expression and replication would be greatly beneficial for neuroscientists. The RABV reverse genetics system reported previously (7) (Fig. 1H) . Their replication was accelerated greatly by blue light illumination (Fig. 1I) . rRABV EGFP -L DMH showed a strong switching-off effect under dark conditions (Fig. 1I) .
The utility of this system as an oncolytic vector was assessed in vivo. Balb-c nu/nu mice bearing MDM-MB-468 cell tumors were treated intratumorally with rMeV EGFP -L DMH . Mice were kept in the dark throughout the day or under the blue light for 12 h/d. Tumors in the phosphate-buffered saline (PBS) injection control group grew aggressively (Fig. 1K) . Treatment with rMeV EGFP -L DMH resulted in a substantial reduction in tumor growth under the blue light (Fig. 1K) . Only rMeV EGFP -L DMHtreated mice under the blue light survived (Fig. 1L) .
This report presents photocontrollable viral vectors using mononegaviruses. The benefits of mononegaviruses in cancer treatment, gene therapy, and regenerative medicine have been comprehensively demonstrated (1-3). We believe that this control strategy of mononegaviruses would enhance the clinical utility of mononegaviruses for state-of-the-art medical treatments. 
Methods
Construction of the Full-Genome MeV and RABV Plasmids. All of the fullgenome MeV plasmids in this study were generated using p(+)MV-IC-EGFP-M/P64S/E89K (6) as the backbone plasmid. To generate the L LMH construct, coding sequences for tandem-linked pMag, Linker, nMagHigh1, and HA tag [Linker MagHigh (LMH)] were inserted into the L gene at the site corresponding to amino acid positions 1708 and 1709 (position 1708/9 ) (the two asparagine residues at positions 1708 and 1709 were removed). The L DMH construct contained tandem linked coding sequences for pMag, nMag, and HA tag [Direct MagHigh (DMH)] at the position 1708/9 . All RABV plasmids in this study were generated using p3.0-GFP (7) as the backbone plasmid. The LMH or DMH coding sequence was inserted into the RABV L gene at the site corresponding to the amino acid position between 1623 and 1625 (position 2) (a lysine residue at position 1624 was removed), generating the fulllength RABV plasmids encoding photocontrollable L proteins.
Intratumor Treatment with Photocontrollable MeV. The breast cancer MDM-MB-468 cell line was obtained from American Type Culture Collection.
Balb-c nu/nu mice, 5 to 6 wk of age (Charles River Laboratories International, Inc.), were injected subcutaneously in the ventral area with 5 × 10 6 MDM- 
